Moderna’s Stock Takes a Nosedive: What Went Wrong?
In a startling twist, Moderna’s stock has plummeted dramatically, leaving investors reeling. Earlier this month, the company enjoyed a significant surge, rising from $39.38 to $47.43 in just a week, fueled by impressive quarterly earnings and a hefty $176 million award aimed